O. Erol Fenercioglu - Istanbul Training & Res Hosp, Clin Nucl Med

基本信息

浏览量：1

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 60 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

The Contribution of 68 Ga-FAPI-04 PET/CT to Staging and Prognosis in Gastric Cancer

Ediz Beyhan,Tevfik Fikret Cermik,Ozge Erol Fenercioglu,Rahime Sahin,Goksel Alcin,Tamer Aksoy,Esra Arslan,Nurhan Ergul

CLINICAL NUCLEAR MEDICINEno. 10 (2024): e485-e491

引用0浏览0WOS引用

Contribution of 68Ga-Dota-fapi-04 PET/CT to Prostate Cancer Imaging

Nurhan Ergul,Tevfik Fikret Cermik,Goksel Alcin,Esra Arslan,Ozge Erol Fenercioglu,Ediz Beyhan,Rahime Sahin, Mehmnet Can Baloglu,Sevim Baykal Koca,Rustu Turkay,Ugur Yucetas

CLINICAL NUCLEAR MEDICINEno. 3 (2024): E105-E110

引用0浏览0引用

Dual ¹⁷⁷Lu-Prostate-Specific Membrane Antigen and ¹⁷⁷Lu-DOTATATE Therapy in Metastatic Castration-Resistant Prostate Cancer With Neuroendocrine Differentiation

Ediz Beyhan,Ozge Erol Fenercioglu,Rahime Sahin,Tevfik Fikret Cermik,Nurhan Ergul

CLINICAL NUCLEAR MEDICINEno. 5 (2024): 447-448

引用0浏览0引用

Contribution of 68 Ga-DOTA-FAPI-04 PET/CT to Prostate Cancer Imaging : Complementary Role in PSMA-Negative Cases

Nurhan Ergül,Tevfik Fikret Çermik,Göksel Alçın,Esra Arslan,Özge Erol Fenercioğlu,Ediz Beyhan,Rahime Şahin, Mehmnet Can Baloğlu,Sevim Baykal Koca,Rüştü Türkay,Uğur Yücetaş

Clinical nuclear medicineno. 3 (2024): e105-e110

引用0浏览0WOS引用

Dual 177 Lu-Prostate-Specific Membrane Antigen and 177 Lu-DOTATATE Therapy in Metastatic Castration-Resistant Prostate Cancer With Neuroendocrine Differentiation

Ediz Beyhan,Özge Erol Fenercioğlu,Rahime Şahin,Tevfik Fikret Çermik,Nurhan Ergül

Clinical nuclear medicineno. 5 (2024): 447-448

引用0浏览0WOS引用

Findings of I-131 SPECT/CT, ≪sup>18</sup>f-Fdg, and ≪sup>68</sup>ga-Fapi-04 PET/CT Imaging in a Patient Treated with Radioiodine Therapy for Metastatic Papillary Thyroid Carcinoma

Gamze Tatar,Göksel Alçın,Özge Erol Fenercioğlu,Rahime Şahin,Tevfik Fikret Çermik

Molecular imaging and radionuclide therapyno. 1 (2023): 57-61

引用0浏览0引用

Findings of I-131 SPECT/CT, 18 F-FDG, and 68 Ga-FAPI-04 PET/CT Imaging in a Patient Treated with Radioiodine Therapy for Metastatic Papillary Thyroid Carcinoma

Gamze Tatar,Göksel Alçın,Özge Erol Fenercioğlu,Rahime Şahin,Tevfik Fikret Çermik

Molecular imaging and radionuclide therapyno. 1 (2023): 57-61

引用1浏览0WOS引用

68Ga-Fapi-04 PET/CT in Selected Breast Cancer Patients with Low FDG Affinity

Göksel Alçın,Esra Arslan,Tamer Aksoy,Merve Cin,Özge Erol Fenercioğlu,Ediz Beyhan,Nurhan Ergül,Tevfik Fikret Çermik

Clinical nuclear medicineno. 9 (2023): e420-e430

引用2浏览0引用

68Ga-Fapi-04 PET/CT Findings in Patients with Liver Cirrhosis

Gamze Tatar,Ediz Beyhan,Ozge Erol Fenercioglu,Isa Sevindir,Nurhan Ergul,Tevfik Fikret Cermik

MOLECULAR IMAGING AND RADIONUCLIDE THERAPYno. 2 (2023): 146-149

引用0浏览0WOS引用

Pneumonia with Intense ≪sup>68</sup>ga-Fapi Uptake Mimicking Metastasis on ≪sup>68</sup>ga-Fapi PET/CT in a Patient with Rectal Cancer

Özge Erol Fenercioğlu,Ediz Beyhan, Neslihan Özyurt,Tevfik Fikret Çermik,Nurhan Ergül

Molecular imaging and radionuclide therapyno. 3 (2023): 237-238

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn